# RIVASTIGMINE
> **ANDA205622** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN TECHNOLOGIES · Approved 2018-06-20
## Drug
- **FDA Application Number:** ANDA205622
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE
- **Generic name:** RIVASTIGMINE
- **Active ingredients:** RIVASTIGMINE
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** MYLAN TECHNOLOGIES
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2018-06-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205622)
---
*MORVS · CC0 1.0*